Home
All Journals
CNS Oncology
List of Issues
Volume 13, Issue 1

CNS Oncology

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

CNS Oncology, Volume 13, Issue 1 (2024)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

CNS Oncology, Volume 13, Issue 1 (2024)

See all volumes and issues

Volume 13, 2024 Vol 12, 2023 Vol 11, 2022 Vol 10, 2021 Vol 9, 2020 Vol 8, 2019 Vol 7, 2018 Vol 6, 2017 Vol 5, 2016 Vol 4, 2015 Vol 3, 2014 Vol 2, 2013 Vol 1, 2012

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Issue In Progress

Case Report

Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma

Steven Du, Dan Beverly Fu, Daniela A Bota & Xiao-Tang Kong

Article: 2345579

Published online: 09 May 2024

AbstractforProlonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma | Full Text | References | PDF (1.3 MB) | EPUB

75 Views
0 CrossRef citations
0Altmetric

Open Access

Case Report

BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab

Toru Imai, Hirokazu Shoji, Hidekazu Hirano, Kunihito Matsuguma, Takahito Awatsu, Toshiharu Hirose, Natsuko Okita, Atsuo Takashima & Ken Kato

Article: 2347824

Published online: 22 May 2024

AbstractforBRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab | Full Text | References | PDF (1.1 MB) | EPUB

58 Views
0 CrossRef citations
0Altmetric

Open Access

Research Article

Article

Perspectives from neuro-oncology providers on patient access to electronic records: a survey study

Keng Lam, Cheuk Hong Leung, Zaid Soomro, Chetna Wathoo & Shiao-Pei Weathers

Article: 2352414

Published online: 28 May 2024

AbstractforPerspectives from neuro-oncology providers on patient access to electronic records: a survey study | Full Text | References | PDF (368.2 KB) | EPUB

0 Views
0 CrossRef citations
0Altmetric

Open Access

Case Report

An adult with recurrent atypical teratoid rhabdoid tumor of the spine

Antoinette J Charles, Vanessa L Smith, C Rory Goodwin & Margaret O Johnson

Article: CNS105

Published online: 21 Feb 2024

AbstractforAn adult with recurrent atypical teratoid rhabdoid tumor of the spine | Full Text | References | PDF (3.1 MB) | EPUB

26 Views
0 CrossRef citations
0Altmetric

Open Access

Case Report

Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review

Nina Yu, Osama A Raslan, Han Sung Lee, Brett J Theeler, Tarek A Raafat, Ruben Fragoso, Kiarash Shahlaie & Orwa Aboud

Article: CNS106

Published online: 13 Feb 2024

AbstractforPromising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review | Full Text | References | PDF (1.6 MB) | EPUB

32 Views
0 CrossRef citations
0Altmetric

Open Access

Short Communication

Rapid Communication

Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity

Edina Komlodi-Pasztor, Vasu Munjapara, Charles G Eberhart, Danielle A Bazer, Mohamed R Sherief, David Olayinka Kamson, Xiaobu Ye, Byram Hirsch Ozer & Matthias Holdhoff

Article: CNS107

Published online: 08 Mar 2024

27 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Perspectives from neuro-oncology providers on patient access to electronic records: a survey study

Keng Lam et al.

Article | Published online: 28 May 2024

Open Access

BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab

Toru Imai et al.

Case Report | Published online: 22 May 2024

Open Access

Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma

Steven Du et al.

Case Report | Published online: 9 May 2024

Open Access

Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity

Edina Komlodi-Pasztor et al.

Rapid Communication | Published online: 8 Mar 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

CNS Oncology (Vol.13, Iss.1, 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?